- ►shouxi.net … , BA Cooperberg, AM Arbelaez, BW Patterson … - Diabetes, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Following preliminary studies that indicated that
a peripheral intravenous insulin dose of 0.1 mU · kg −1 · min −1 (lower
than those used previously) provides basal insulin replacement and that a ... Cited by 3 - Related articles - BL Direct - All 9 versions
P Wiesli, R Lehmann, PA Krayenbuehl, C … - Experimental and clinical endocrinology & diabetes: …, 2006 - ncbi.nlm.nih.gov AIMS: Characterizing the time course of the rise of blood glucose concentrations
in the fasting state during the day and night in patients with type 2 diabetes.
METHODS: 40 consecutive insulin-treated patients with type 2 diabetes ... Cited by 3 - Related articles - BL Direct - All 3 versions
- ►endojournals.org C Meyer, P Saar, N Soydan, M Eckhard, RG … - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc Context: During hypoglycemia, systemic glucose uptake (SGU) decreases and
endogenous glucose release (EGR) increases. Skeletal muscle appears to be
primarily responsible for the reduced SGU and may be important for the ... Cited by 3 - Related articles - BL Direct - All 4 versions
- ►edulife.com.br [PDF] J Radziuk, S Pye - Diabetologia, 2006 - Springer Abstract Aims/hypothesis: An increase in endogenous glucose production (EGP) is
a major contributor to fasting morning hyperglycaemia in type 2 diabetes. This
increase is dissipated with fasting, later in the day. To understand its ... Cited by 5 - Related articles - BL Direct - All 5 versions
HE Scholtz, SG Pretorius, DH Wessels, C … - Acta Diabetologica, 2003 - Springer Abstract The absolute glucose disposal of insulin glargine (Lantus) was compared
to that of regular human insulin in healthy subjects (n=20) using the
euglycaemic clamp tech- nique in a single-dose, double-blind, randomized, ... Cited by 5 - Related articles - BL Direct - All 3 versions
SJ Friedberg, YWF Lam, JJ Blum, RI … - Metabolism, 2006 - Elsevier Our experience over many years from 2 diabetes clinics with large patient
populations indicated that, apparently, excessive doses of intermediate-acting
insulin preparations (150-300 U of NPH insulin), alone or in combination ... Cited by 6 - Related articles - All 10 versions
K Tanjoh, R Tomita, M Fukuzawa, N Hayashi - Hepato-gastroenterology, 2003 - cat.inist.fr Background/Aims: Although glucagon has been detected even in the serum of
totally pancreatectomized patients and the origin was suggested to be the
intestine, the kinetics of glucagon are not well known after ... Cited by 2 - Related articles - BL Direct - All 3 versions
- ►physiology.org [PDF] SM Breckenridge, B Raju, AM Arbelaez, BW … - American Journal of Physiology- Endocrinology And …, 2007 - Am Physiological Soc Page 1. E-00325-2007 Revision Basal Insulin, Glucagon and Growth Hormone Replacement
Suzanne M. Breckenridge Bharathi Raju Ana Maria Arbelaez Bruce W. Patterson ... Cited by 2 - Related articles - BL Direct - All 4 versions
[CITATION] … on endogenous glucose output and peripheral activation/deactivation kinetic profiles
R Rizza, C Verdonk, J Miles… - Hormone and metabolic research. Hormon-und …, 1979 - ncbi.nlm.nih.gov 1: Horm Metab Res. 1979 Nov;11(11):643-4. Somatostatin does not cause
sustained fasting hyperglycemia in man. Rizza R, Verdonk C ... Cited by 2 - Related articles
